HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
PATH
NuPathe Inc
Healthcare Biotechnology Delisted · Pennsylvania, USA · Reports in usd
$9.38
Market Cap: $5.63B
Market Cap
$5.63B
Enterprise Val
$4.40B
P/E Ratio
17.20
P/B Ratio
2.96
Trailing PEG (1Y)
-0.09
As Of
Jun 9, 2026

Overview & Key Metrics

Reporting period: Apr 30, 2026 · Q1 2026
Book Value$1.90B
Gross Margin81.61%
Profit Margin81.61%
Return on Equity17.29%
Return on Assets11.32%
Current Ratio2.31
Debt/Equity0.04
LT Debt/Equity0.04
Revenue Per Share0.80

Income Statement

Apr 30, 2026
Revenue$418.4M
Cost of Revenue$76.9M
Gross Profit$341.5M
R&D$92.9M
SG&A$220.6M
Operating Expenses$313.5M
Operating Income$28.0M
Interest Expense$0.00
Tax Expense$18.4M
Net Income$22.5M
EPS (Basic)$0.04
EPS (Diluted)$0.04
EBIT$41.0M
EBITDA$52.8M
Consolidated Income$22.5M
Non-Controlling Interests$0.00

Balance Sheet

Apr 30, 2026
Cash & Equivalents$633.7M
Accounts Receivable$300.0M
Inventory$0.00
Current Assets$1.92B
LT Investments$108.5M
Property, Plant & Equipment$112.0M
Intangibles$285.8M
Non-Current Assets$986.3M
Total Assets$2.90B
Accounts Payable$19.7M
Current Debt$0.00
Current Liabilities$831.7M
LT Debt$72.0M
Non-Current Liabilities$170.1M
Total Liabilities$1.00B
Total Debt$72.0M
Retained Earnings-$1.68B
Shareholder Equity$1.90B
Shares Outstanding523,921,872

Cash Flow Statement

Apr 30, 2026
Operating Cash Flow$131.9M
Investing Cash Flow-$112.8M
Financing Cash Flow-$252.2M
CapEx-$2.7M
Free Cash Flow$129.2M
Depreciation & Amort.$11.8M
Stock-Based Comp$53.3M
Acquisitions / Disposals-$149.4M
Investment Activity$34.6M
Debt Issued/Repaid$0.00
Equity Issued/Repaid-$243.4M
Dividends Paid$0.00
Net Change in Cash-$237.9M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h